Clinical trial
The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in…
NCT00141544 · Solvay Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00141544 |
|---|---|
| Title | The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women |
| Official title | A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Menopause |
| Intervention type | Drug |
| Interventions | esterified estrogens 1.25 mg and methyltestosterone 2.5 mg, Esterified estrogens 1.25 mg |
| Enrollment | 28 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Apr 11, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: